Engy Habashy, MD, discusses key takeaways from the 2025 AUA GSM guideline, including the role of androgens and hormonal therapies in managing genitourinary syndrome of menopause.
|Videos|January 2, 2023
Dr. Findlay on the lack of female representation in urology: “We still have a lot of room to grow"
Author(s)Urology Times staff
“We need to be focusing our efforts on early exposure to the field for women and underrepresented groups,” says Bridget Lang Findlay, MD.
Advertisement
In this interview, Bridget Lang Findlay, MD, discusses key takeaways from the recent study, “Path to parity: Trends in female representation among physicians, trainees, and applicants in urology and surgical specialties” and postulates ways to build off the findings moving forward. Findlay is a urology resident at Mayo Clinic in Rochester, Minnesota.
Advertisement
Related to this article
These FAQs outline key recommendations and practical takeaways from the AUA/SUFU/AUGS Genitourinary Syndrome of Menopause guideline.
Advertisement
Advertisement
Trending on Urology Times
1
ESMO 2026: Key presentations across genitourinary oncology
2
Darolutamide associated with less cognitive change than enzalutamide in prostate cancer
3
How PSMA-PET shapes staging and recurrence workup in prostate cancer
4
KLK2-comPAS trial explores dual T-cell engagement in mCRPC
5